PCSK9 and atherosclerosis: This conclusion was supported by studies that showed that in mice the absence of PCSK9 substantially reduces the development of atherosclerosis (103), apoB levels, and endothelial dysfunction (104) and that its overexpression does the reverse (103, 105, 106).